Molecular Signaling Pathways Mediating Osteoclastogenesis Induced by Prostate Cancer Cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Molecular Signaling Pathways Mediating Osteoclastogenesis Induced by Prostate Cancer Cells ; volume:13 ; number:1 ; day:26 ; month:12 ; year:2013 ; pages:1-12 ; date:12.2013
BMC cancer ; 13, Heft 1 (26.12.2013), 1-12, 12.2013
- Urheber
-
Rafiei, Shahrzad
- Beteiligte Personen und Organisationen
-
Komarova, Svetlana V.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-13-605
- URN
-
urn:nbn:de:1111-201603048466
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rafiei, Shahrzad
- Komarova, Svetlana V.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
Independence of HIF1a and androgen signaling pathways in prostate cancer
The role of LncRNAs and CircRNAs in osteoporosis: a focus on osteogenesis and osteoclastogenesis signaling pathways
Picrasidine I from Picrasma Quassioides Suppresses Osteoclastogenesis via Inhibition of RANKL Induced Signaling Pathways and Attenuation of ROS Production
Impact of artificial extracellular matrix components on osteoclastogenesis and osteoclast signaling
Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling
The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis
Endocytic pathways mediating oligomeric Aβ42 neurotoxicity
Metformin regulates multiple signaling pathways within castration-resistant human prostate cancer cells
Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways
Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosis
Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
Independence of HIF1a and androgen signaling pathways in prostate cancer
The role of LncRNAs and CircRNAs in osteoporosis: a focus on osteogenesis and osteoclastogenesis signaling pathways
Picrasidine I from Picrasma Quassioides Suppresses Osteoclastogenesis via Inhibition of RANKL Induced Signaling Pathways and Attenuation of ROS Production
Impact of artificial extracellular matrix components on osteoclastogenesis and osteoclast signaling
Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling
The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis
Endocytic pathways mediating oligomeric Aβ42 neurotoxicity
Metformin regulates multiple signaling pathways within castration-resistant human prostate cancer cells
Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways
Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosis
Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
Independence of HIF1a and androgen signaling pathways in prostate cancer
The role of LncRNAs and CircRNAs in osteoporosis: a focus on osteogenesis and osteoclastogenesis signaling pathways
Picrasidine I from Picrasma Quassioides Suppresses Osteoclastogenesis via Inhibition of RANKL Induced Signaling Pathways and Attenuation of ROS Production
Impact of artificial extracellular matrix components on osteoclastogenesis and osteoclast signaling
Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling
The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis
Endocytic pathways mediating oligomeric Aβ42 neurotoxicity
Metformin regulates multiple signaling pathways within castration-resistant human prostate cancer cells
Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways